Impact of a simple regimen of low molecular weight heparin (reviparin) in preventing mortality, reinfarction, and strokes in over 15,500 patients with ST-elevation acute myocardial infarction: The CREATE trial
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- February 1, 2005
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1117 Public Health and Health Services (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- American Heart Journal Journal